

HY-145406 · 50 mg
MedChemExpress · Cat: HY-145406
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/ihch-3064.htmlDescription
IHCH-3064 is a dual-acting compounds targeting Adenosine A2A Receptor and HDAC. IHCH-3064 exhibits potent binding to A2AR Ki=2.2 nM and selective inhibition of HDAC1 IC50=80.2 nM , with good antiproliferative activity against tumor cell lines in vitro. IHCH-3064 is a tumor immunotherapeutic agent.





